Global independent biometrics company, Quartesian, acquired by Summit Partners to form key pillar of newly established global outsourced medtech services provider.
Quartesian’s global reach and innovative capabilities made them an ideal fit for Summit Partners’ newly formed Veranex, the first-of-its-kind, single-partner, comprehensive medical technology solutions provider. The resulting acquisition formed a key pillar of the new platform, in which Quartesian’s agility and reputation for excellence will help qualify Veranex to service the world’s largest medical device companies with a unified development process.
Crosstree helped Quartesian find the ideal financial partner for the next phase of their growth:
- Leveraging market expertise to attract seasoned investors who understood Quartesian’s value
- Identifying a financial partner with the right strategic fit for all stakeholders